Fexofenadine Hydrochloride Oral · FEXOFENADINE HYDROCHLORIDE 30 mg/5mL · Suspension · Oral · Aurohealth LLC
NDC 58602-0426-20 · 1 BOTTLE in 1 CARTON / 240 mL in 1 BOTTLE · ANDA · View full market →
Only one company currently supplies this market — there is no backup if it stumbles. Historically, drugs in this position went on to a new shortage within 90 days about 0.3% of the time — roughly 2× the typical drug (0.1%).
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Not scored — fragility is computed for NADAC-priced NDCs.
price up 92% YoY · sole-source market
For scale: the typical drug’s chance is about 0.1% — this one is 2× that.
Backtested statistical model over the whole market, not this package alone. Model details →
No FDA shortage reports for this drug or its presentations.
No enforcement reports list this package NDC.
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Aurohealth LLC | FEXOFENADINE HYDROCHLORIDE 30 mg/5mL | Jul 15, 2026 | Sep 2, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
DrugDashboards, "Fexofenadine Hydrochloride — NDC 58602-0426-20," retrieved September 3, 2026, https://drugdashboards.com/drug/58602042620.
Free to cite with attribution — see how the data is put together.